Health: Biometrics News

Today is March 19, 2024. All times in Eastern Daylight Time.

Natera Announces Phase III Randomized CIRCULATE Trial in France, Evaluating Signatera™ in Stage II Colorectal Cancer

03/18/2024 - 07:00 AM

BUSINESS WIRE
Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq

03/14/2024 - 09:38 AM

BUSINESS WIRE
AI-Powered Jumio Platform Wins Gold for Identity Proofing and Corroboration in the 2024 Globee Awards for Cybersecurity

03/14/2024 - 06:00 AM

BUSINESS WIRE
ŌURA Files ITC Action Against Ultrahuman, RingConn, and Circular for Patent Infringement

03/13/2024 - 05:35 PM

BUSINESS WIRE
Reperio Health and Applied Health Analytics Partner to Support Health Systems with Population Health Insights

03/13/2024 - 09:03 AM

BUSINESS WIRE
Vizgen Announces Denial of 10x Genomics’ Petition for Inter Partes Review of Vizgen-Licensed Patent Currently Asserted Against 10x’s Xenium Platform

03/13/2024 - 08:00 AM

BUSINESS WIRE
City of Hope to Present New Research at the American Association of Cancer Research (AACR) Annual Meeting 2024, Highlighting Promising Data on Prostate, Colorectal and Pancreatic Cancer

03/12/2024 - 12:00 PM

BUSINESS WIRE
Beckman Coulter与Fujirebio扩大合作，开发患者易用的基于血液的神经退行性疾病诊断方法

03/12/2024 - 10:00 AM

BUSINESS WIRE
Beckman Coulter e Fujirebio expandem parceria para desenvolver diagnósticos de doenças neurodegenerativas com base no sangue e fáceis de usar para os pacientes

03/12/2024 - 10:00 AM

BUSINESS WIRE
Beckman Coulter y Fujirebio amplían su colaboración para desarrollar pruebas de diagnóstico de enfermedades neurodegenerativas en sangre que no generen un trastorno a los pacientes

03/12/2024 - 10:00 AM

BUSINESS WIRE
Riassunto: Beckman Coulter e Fujirebio ampliano la loro partnership per sviluppare diagnosi delle malattie neurodegenerative orientate al paziente, in base a prelievi del sangue

03/12/2024 - 10:00 AM

BUSINESS WIRE
Beckman Coulter和Fujirebio擴大合作夥伴關係，開發病人友善、基於血液的神經退化性疾病診斷

03/12/2024 - 10:00 AM

BUSINESS WIRE
Beckman Coulter und Fujirebio bauen Partnerschaft zur Entwicklung patientenfreundlicher, auf Blut basierender Diagnostika für neurodegenerative Erkrankungen aus

03/12/2024 - 10:00 AM

BUSINESS WIRE
Beckman Coulter et Fujirebio élargissent leur partenariat pour développer des diagnostics sanguins adaptés aux patients pour les maladies neurodégénératives

03/12/2024 - 10:00 AM

BUSINESS WIRE
Beckman Coulter and Fujirebio Expand Partnership to Develop Patient-friendly, Blood-based Neurodegenerative Disease Diagnostics

03/12/2024 - 10:00 AM

BUSINESS WIRE

1 2 3 4

Next »

Search